Lawsuit Filed After Patient Suffers Life-Threatening Bleeding from
A Montana patient recently filed a lawsuit against the manufacturer of the popular anticoagulant due to complications he suffered while taking the medication.
Allegedly, plaintiff Gregory E. took from August 2013 to September 2015 and suffered from life-threatening bleeding from during that time. Bleeding risks, if not caught early, could lead to catastrophic injuries, organ damage, or even death.
Life-Threatening Bleeding from : Patients Report Complications
If you or someone you know has sustained these kinds of complications or serious side effects as a result of taking , you need to consult with an experienced attorney as soon as possible. Being able to articulate your concerns to a lawyer may help you to recover compensation from the manufacturer.
was first introduced in the United States in 2011 as a new oral anticoagulant.
Manufacturer Janssen Research & Development, an arm of Johnson & Johnson Pharmaceutical Research and Development LLC is named in the lawsuit for allegedly marketing a dangerous drug without giving patients or doctors appropriate information about the serious side effects, including life-threatening bleeding from that could result.
Any patient currently taking should be aware of the potential dangers and may want to talk to his or her doctor.
was marketed as replacement for blood-thinning drugs such as warfarin and has been advertised as a safe treatment for preventing stroke or systemic embolism. Recent academic studies and reports from patients who have been injured by this drug, however, indicate that warfarin may be a safer alternative to and similar drugs due to the fact that some patients experience higher rates of life-threatening bleeding from .
What’s Alleged in the Newest Lawsuit
According to the lawsuit filed against the maker of this allegedly dangerous drug, without appropriate blood monitoring or dose adjustment, taking this medication twice a day can lead to life-threatening bleeding from . The lawsuit argues that the defendants were aware of this risk and failed to notify patients and physicians about the severe or fatal internal bleeding risk associated with the drug.
The adverse events reported by patients taking have been recorded by the FDA, and now, a growing number of patients in this situation who have experienced life-threatening bleeding from are considering filing a lawsuit to recover compensation.
A patient expects that a drug developer and manufacturer has done all the necessary work in order to decrease the risk of injury or to make the patient aware of the risks. When that does not happen, however, which may be the case with life-threatening bleeding from , you may be entitled to fight for compensation in court. Drug manufacturers have a responsibility to safely create, make, and market medications.
If you or someone you know has suffered life-threatening bleeding from , the attorneys at McDonald Worley have extensive experience holding manufacturers of dangerous and defective drugs accountable in court. Fill out the form on this page for a free case evaluation.